Europe Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, and Other POC Products), Prescription Mode (Prescription-Based Testing and OTC Testing), and End User (Professional Diagnostic Centers, Home Care, Research Laboratories, and Others)
Market Introduction
Europe is the second-largest market for point of care diagnostics, and the UK, Germany, France, Italy, Spain, and rest of Europe are the major contributors to this market in this region. The growth of the market in Europe is characterized by the rise in the demand for advanced diagnostic solutions, rising prevalence of infectious and chronic conditions, and increase in the investment for research and development. Also, the presence of well-established manufacturing infrastructure for advanced diagnosis products is likely to propel the growth of the Europe point of care diagnostics market during the forecast period. Germany led the market. The government of Germany is putting efforts to improve the medical conditions for the people suffering from various health conditions. For instance, in November 2017, Lilly Germany developed the Diabetes Work initiative. The initiative was launched to spread the awareness regarding diabetes, which is expected to offer a lucrative opportunity for adoption of diagnostic kits. Further, in September 2018, the Germany government gave permission to market and sale OTC HIV home testing kits. Such constructive developments are projected to drive the growth of Europe point of care diagnostics market during the forecast period.
In case of COVID-19, Europe is highly affected specially France. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries and number of deaths are also high. The current coronavirus (COVID-19) outbreak has been declared by WHO as a Public Health Emergency of International Concern, according to the International Health Regulation. Increasing number of coronavirus infections and demand for advanced diagnostic solutions is offering a favorable opportunity for adoption of point of care diagnostic kits in the region. Moreover, rising investments and business activities by industry players is also boosting the market even in pandemic situations. In 2020, European Medicines Agency (EMA) approved about 97 medicines for marketing authorization of which, 39 are novel drugs. Similarly, in October 2020, Eurofins introduces COVID-19 PCR tests with at-home self-sampling options in Europe region. Moreover, in October 2020, Siemens Healthineers launched rapid antigen test for diagnosis of COVID-19 in European countries. The CLINITEST rapid COVID-19 test is point of care cassette test that offers test result in 15 minutes. In addition, in April 2021, QIAGEN announced launch of Prep&Amp technology in order accelerate the COVID-19 diagnosis in Europe. The kit has received CE approval for marketing and distribution in Europe, also, the company has submitted its product for EUA (Emergency Use Application) in US. Such activities are likely to have constructive impact on market growth.
Get more information on this report :
Market Overview and Dynamics
The Europe point of care diagnostics market is expected to grow from US$ 8,948.81 million in 2021 to US$ 20,207.60 million by 2028; it is estimated to grow at a CAGR of 12.3% from 2021 to 2028. Burgeoning use of home-based poc devices is expected to escalate the market growth. The increasing awareness about point of care testing is bringing the test conveniently and quickly to the patient at home. Most clinicians recognize POC testing as a requirement for early detection of life-threatening situations because laboratory results can be made available in real-time. POC diagnostic and monitoring devices are anticipated to become universal in-home setups as well as at doctor’s offices or hospitals, in low- and middle-income countries. Consumers are frequently using smartphones as platform devices. The health and monitoring applications of smartphones commonly include imaging, sensing, and diagnostics. Although glucose meters are widely used in home settings by diabetic patients, they can also be repurposed to perform common clinical assays such as immunoassays, molecular diagnostics, and enzymatic assays. The rise in geriatric population has resulted in increased expenditure on healthcare for health checkups, disease diagnoses, and treatments. The most constant health problems affecting this population include digestive disorders, cardiovascular diseases, bone and joint diseases, diabetes, and different types of cancer. The people of this age group claim diagnostic testing on a regular basis, owing to their low immunity and metabolism. Therefore, these factors have increased the demand of POCs for diagnostic purposes across Europe region.
Key Market Segments
In terms of product, the glucose monitoring products segment accounted for the largest share of the Europe point of care diagnostics market in 2020. In terms of prescription mode, the prescription-based testing segment held a larger market share of the Europe point of care diagnostics market in 2020. Further, the professional diagnostic centers segment held a larger share of the Europe point of care diagnostics market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Europe point of care diagnostics market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Danaher; F. HOFFMANN-LA ROCHE LTD.; Johnson and Johnson Services, Inc.; Nova Biomedical; Polymer Technology Systems, Inc. (PTS); and Siemens AG.
Reasons to buy report
- To understand the Europe point of care diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe point of care diagnostics market
- Efficiently plan M&A and partnership deals in Europe point of care diagnostics market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe point of care diagnostics market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.
Europe Point of Care Diagnostics Market Segmentation
Europe Point of Care Diagnostics Market - By Product
- Glucose Monitoring Products
- Infectious Disease Testing Products
- HIV Testing
- Influenza Testing
- Sexually Transmitted Disease (STD) Testing
- Hepatitis C Testing
- Healthcare-Associated Infection (HAI) Testing
- Tropical Disease Testing
- Respiratory Infection Testing
- Other Infectious Disease Testing
- Cardiometabolic Testing Products
- Pregnancy and Fertility Testing Products
- Coagulation Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Hematology Testing Products
- Other POC Products
Europe Point of Care Diagnostics Market - By Prescription Mode
- Prescription-Based Testing
- OTC Testing
Europe Point of Care Diagnostics Market - By End User
- Professional Diagnostic Centers
- Hospitals
- Clinical Laboratories
- Outpatient Healthcare
- Ambulatory Care Settings
- Home Care
- Research Laboratories
- Others
Europe Point of Care Diagnostics Market - By Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Europe Point of Care Diagnostics Market - Company Profiles
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Point of Care Diagnostics Market – By Product
1.3.2 Europe Point of Care Diagnostics Market – By Prescription Mode
1.3.3 Europe Point of Care Diagnostics Market – By End User
1.3.4 Europe Point of Care Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Point of Care Diagnostics Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
5. Europe Point of Care Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Infectious Diseases
5.1.2 Escalating Product Launches and Product Developments
5.1.3 Growing Number of CLIA-waived POC tests
5.2 Market Restraints
5.2.1 Increasing Product Recalls in Market
5.3 Market Opportunities
5.3.1 Escalating Number of Conferences and Events
5.4 Future Trends
5.4.1 Burgeoning Use of Home-Based POC Devices
5.5 Impact Analysis
6. Point of Care Diagnostics Market – Europe Analysis
6.1 Europe Point of Care Diagnostics Market Revenue Forecast and Analysis
7. Europe Point of Care Diagnostics Market Analysis– by Product
7.1 Overview
7.2 Europe Point of Care Diagnostics Market, By Product 2020 & 2028 (%)
7.3 Glucose Monitoring
7.3.1 Overview
7.3.2 Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Infectious Disease Testing
7.4.1 Overview
7.4.2 Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 HIV Testing
7.4.3.1 Overview
7.4.3.2 HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Influenza Testing
7.4.4.1 Overview
7.4.4.2 Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Sexually Transmitted Disease (STD) Testing
7.4.5.1 Overview
7.4.5.2 Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Hepatitis C Testing
7.4.6.1 Overview
7.4.6.2 Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Healthcare-Associated Infection (HAI) Testing
7.4.7.1 Overview
7.4.7.2 Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.8 Tropical Disease Testing
7.4.8.1 Overview
7.4.8.2 Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.9 Respiratory Infection Testing
7.4.9.1 Overview
7.4.9.2 Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.10 Other Infectious Disease
7.4.10.1 Overview
7.4.10.2 Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Cardiometabolic Testing
7.5.1 Overview
7.5.2 Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Pregnancy and Fertility Testing
7.6.1 Overview
7.6.2 Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Coagulation Testing
7.7.1 Overview
7.7.2 Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.8 Tumor/Cancer Marker Testing
7.8.1 Overview
7.8.2 Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.9 Cholesterol Testing
7.9.1 Overview
7.9.2 Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.10 Urinalysis Testing
7.10.1 Overview
7.10.2 Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.11 Haematology Testing
7.11.1 Overview
7.11.2 Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)
7.12 Other POC
7.12.1 Overview
7.12.2 Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
8. Europe Point of Care Diagnostics Market Analysis– by Prescription Mode
8.1 Overview
8.2 Europe Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)
8.3 Prescription-Based Testing Market
8.3.1 Overview
8.3.2 Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 OTC Testing Market
8.4.1 Overview
8.4.2 OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
9. Europe Point of Care Diagnostics Market Analysis– by End User
9.1 Overview
9.2 Europe Point of Care Diagnostics Market, By End User 2020 & 2028 (%)
9.3 Professional Diagnostic Centers
9.3.1 Overview
9.3.2 Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.3 Hospitals
9.3.3.1 Overview
9.3.3.2 Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.4 Clinical Laboratories
9.3.4.1 Overview
9.3.4.2 Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5 Outpatient Healthcare
9.3.5.1 Overview
9.3.5.2 Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.6 Ambulatory Care Settings
9.3.6.1 Overview
9.3.6.2 Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Home Care
9.4.1 Overview
9.4.2 Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecasts to 2028 (US$ Mn)
10. Europe Point of Care Diagnostics Market – Country Analysis
10.1 Europe: Point of Care Diagnostics Market
10.1.1 Overview
10.1.2 Europe: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.1.3 UK: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.1 UK: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.2 UK: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.3.2.1 UK: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.3.3 UK: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.3.4 UK: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.3.4.1 UK: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.4 Germany: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Germany: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Germany: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.4.2.1 Germany: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.4.3 Germany: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.4.4 Germany: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.4.4.1 Germany: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.5 France: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.1 France: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.2 France: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.5.2.1 France: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.5.3 France: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.5.4 France: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.5.4.1 France: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.6 Italy: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.1 Italy: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Italy: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.6.2.1 Italy: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.6.3 Italy: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.6.4 Italy: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.6.4.1 Italy: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.7 Spain: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.7.1 Spain: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.7.2 Spain: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.7.2.1 Spain: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.7.3 Spain: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.7.4 Spain: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.7.4.1 Spain: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.8 Rest of Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Rest of Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Rest of Europe: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.8.2.1 Rest of Europe: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.8.3 Rest of Europe: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.8.4 Rest of Europe: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.8.4.1 Rest of Europe: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Point of Care Diagnostics Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BIO-RAD LABORATORIES INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Polymer Technology Systems, Inc. (PTS)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Nova Biomedical
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. UK: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 3. UK: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 4. UK: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 5. UK: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 6. UK: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 7. Germany: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 8. Germany: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 9. Germany: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 10. Germany: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Germany: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 12. France: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 13. France: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 14. France: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 15. France: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 16. France: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 17. Italy: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 18. Italy: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 19. Italy: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 20. Italy: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 21. Italy: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 22. Spain: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 23. Spain: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 24. Spain: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 25. Spain: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 26. Spain: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Europe: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Europe: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Europe: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Europe: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Europe: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 32. Recent Organic Developments the Point of Care Diagnostics Market
Table 33. Recent Inorganic Developments in the Point of Care Diagnostics Market
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Point of Care Diagnostics Market Segmentation
Figure 2. Europe Point of Care Diagnostics Market Segmentation, By Country
Figure 3. Europe Point of Care Diagnostics Market Overview
Figure 4. Prescription-Based Testing Segment Held Largest Share of Europe Point of Care Diagnostics Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Impact Analysis of Driver and Restraints Pertaining to Europe Point of Care Diagnostics Market
Figure 8. Europe Point of Care Diagnostics Market – Revenue Forecast and Analysis
Figure 9. Europe Point of Care Diagnostics Market, by Products 2020 & 2028 (%)
Figure 10. Europe Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Europe Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Europe Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Europe Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Europe Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Europe Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Europe Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Europe Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Europe Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Europe Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Europe Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Europe Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Europe Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Europe Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Europe Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)
Figure 29. Europe Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Europe OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Europe Point of Care Diagnostics Market, by End User 2020 & 2028 (%)
Figure 32. Europe Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. Europe Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Europe Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Europe Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Europe Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. Europe Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. Europe Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 39. Europe Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. Europe: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 41. Europe: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 42. UK: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Germany: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. France: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Italy: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Spain: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. Rest of Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. Impact of COVID-19 Pandemic in European Country Markets
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe point of care diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in Europe point of care diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the point of care diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution